clinical trials
The London-based company most recently raised £5 million in Series A funding in 2020.
HIMSS22
In a preview of her HIMSS22 session, Abbott's Jennifer Jones-McMeans explains how clinical studies can be structured to ensure a diverse population of participants.
The market is forecast to reach $9.13 billion (€7.84 billion) by 2026.
Panelists said better data collection and decentralized clinical trials may be one way to boost diversity efforts.
THREAD Research CEO John Reites speaks on the state of remote and hybrid trials, and how COVID-19 has accelerated an already blossoming field.
Asset Management Ventures' Skip Fleshman outlines COVID-19's impact on clinical trials and the resulting leap toward tech-enabled decentralized trials.
The company will expand its oncolytic viral therapy platform to combat cancer.
The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors such as patient population recruitment and dropout rate.
The capital raised will also increase its team of clinical trial experts in serving both pharma and patients across the UK and overseas.
The funding will also help get much-needed therapies to patients faster.